Silencing α5nAChR inhibits keratinocyte proliferation and reduces psoriasis severity in α5nAChR-knockout mice by modulating the mitogen-activated protein kinase (MAPK)/nuclear factor kappa β (NF-κB) pathway [11]. This evidence concerns the gene NFKB1 and psoriasis.